ArticleFrontiers in psychiatry2026
Ventricular cardiac magnetic resonance traits and schizophrenia risk: a UK Biobank and Mendelian randomization study.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Genetic factors can influence variation in cardiac structure. Schizophrenia (SCZ) is also highly heritable. However, whether cardiac structural variation is related to SCZ risk remains unclear and insufficiently examined from a "heart-to-brain" perspective. Methods: Using data from 38,206 UK Biobank (UKB) participants, we assessed associations between 16 cardiac magnetic resonance imaging-derived ventricular traits and SCZ polygenic risk scores. Using ventricular cardiac magnetic resonance traits Genome-wide association study (GWAS) data from over 30,000 individuals and SCZ GWAS data from 127,906 individuals, two-sample Mendelian randomization (MR) was performed to evaluate potential causal associations. Reverse association analysis using data from UKB and reverse MR analysis were conducted to explore possible reverse effects. Results: Four ventricular traits showed significant associations with SCZ genetics, with end-systolic volume (ESV) of right ventricle (RV) exhibiting the strongest negative association. Forward MR provided evidence consistent with a potential causal association between genetically predicted higher ESV of RV and lower SCZ risk, with no strong indication of pleiotropy. All other traits in the forward MR analyses, as well as all traits in the reverse MR analyses, showed no statistically significant evidence of a potential causal association. Conclusions: Higher genetically predicted ESV of RV appears linked to reduced SCZ risk. These findings highlight ESV of RV as a ventricular characteristic with genetic relevance to SCZ. This study offers new insights into SCZ pathophysiology and opportunities for risk stratification and mechanistic investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.